Last updated: June 18, 2024
Sponsor: Seoul National University Hospital
Overall Status: Completed
Phase
N/A
Condition
Sarcopenia
Polymyositis (Inflammatory Muscle Disease)
Treatment
Placebo
GI Biome #7
Clinical Study ID
NCT05735418
GIB-2022-088
Ages > 60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
60 years old or older
Those who have no difficulties in daily living
Willing to commit throughout the study
Exclusion
Exclusion Criteria:
Antibiotics medication in the last month.
Probiotics used in the last months.
Those who are in the treatment of the following diseases: Liver disease,Neurological disease, Respiratory disease, Tumors, Psychiatric disorders, Angina,Myocardial infarction, and Stroke
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
January 13, 2023
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
Seoul National University College of Medicine
Seoul, 03080
Korea, Republic ofSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.